Latest Breaking News On - Orphan drug status - Page 3 : comparemela.com

X4 Pharmaceuticals Announces Submission of New Drug Application (NDA) to U S FDA for Mavorixafor in WHIM Syndrome

X4 Pharmaceuticals Announces Submission of New Drug Application (NDA) to U S FDA for Mavorixafor in WHIM Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPaula raganBrett whelanExchange commissionClinical immunology societyEuropean hematology associationPharmaceuticals nasdaqEuropean unionLifesci communicationsDrug administrationNew drug applicationUnited states foodChief executive officerBreakthrough therapy designationFast track designationRare pediatric designation

AstraZeneca files litigation to challenge Inflation Reduction Act

The program faces at least seven other court challenges, including from leading industry group PhRMA and drugmakers Johnson & Johnson, Merck & Co, Bristol Myers Squibb and privately-held Boehringer Ingelheim. The drug price negotiation program is part of President Joe Biden's signature Inflation Reduction Act (IRA). AstraZeneca said it was filing the legal challenge to "protect timely access to medicines for orphan indications" in the United States.

United statesUnited kingdomJoe bidenBhanvi satijaShilpi majumdarDhanya ann thoppilPresident joe bidenInflation reduction actDrug pricesOrphan drug statusPresident joe biden

NovAccess Global Inc : NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform

NovAccess Global Inc : NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDwaink irvinAndrew norrisNational institutes of healthNovaccess global inc viewUniversity of california los angelesDarrow associatesSecurities exchangeKansas university medical centerDrug administrationSecurities exchange commissionPrecision medicine divisionNovaccess global incOur companyDevelopment beginsFourth generation

NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform

NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

United statesDwaink irvinAndrew norrisPrecision medicine divisionNational institutes of healthOur companyUniversity of california los angelesNovaccess global incKansas university medical centerSecurities exchangeSecurities exchange commissionDrug administrationDarrow associatesDevelopment beginsFourth generationPrimary drug

NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform

NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
baltimorestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimorestar.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew norrisDwaink irvinPrecision medicine divisionSecurities exchange commissionNational institutes of healthDarrow associatesOur companyKansas university medical centerSecurities exchangeNovaccess global incUniversity of california los angelesDrug administrationDevelopment beginsFourth generationPrimary drug